The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR
Clinical trial NCT07159087 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07159087
- Sponsor
- Genoss Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-19
- Primary completion
- 2026-07-31
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.